National Peroxide Ltd is Rated Hold

Current Rating and Its Significance

On 17 June 2026, National Peroxide Ltd’s rating was revised to 'Hold' from a previous 'Buy' rating, accompanied by a decrease in its Mojo Score from 70 to 63. This rating indicates a cautious stance, suggesting that while the stock remains a viable investment, it may not offer the same upside potential as before. Investors should interpret this as a signal to maintain existing positions rather than aggressively accumulate shares at this stage.

Here’s How the Stock Looks Today

As of 10 July 2026, National Peroxide Ltd’s financial and market data present a nuanced picture. The company operates within the Commodity Chemicals sector and is classified as a microcap stock. Despite some positive momentum in recent months, the stock’s overall performance has been mixed, with a one-year return of -17.93%, underperforming the broader BSE500 index, which declined by -2.37% over the same period.

Quality Assessment

The quality grade for National Peroxide Ltd is below average, reflecting challenges in its long-term fundamental strength. The company has experienced a compound annual growth rate (CAGR) of -24.68% in operating profits over the past five years, signalling persistent operational headwinds. Additionally, the average Return on Equity (ROE) stands at a modest 2.63%, indicating limited profitability relative to shareholders’ equity. This subdued profitability suggests that the company has struggled to generate strong returns on invested capital, which is a key consideration for investors seeking quality growth stocks.

Valuation Perspective

Contrasting its quality concerns, National Peroxide Ltd’s valuation is currently attractive. The stock trades at a Price to Book (P/B) ratio of 0.9, which is below the average historical valuations of its peers in the commodity chemicals sector. This discount suggests that the market may be undervaluing the company relative to its net asset base. Furthermore, the company’s Price/Earnings to Growth (PEG) ratio is an exceptionally low 0.1, reflecting strong profit growth relative to its price. This valuation metric indicates potential value for investors willing to look beyond short-term challenges.

Financial Trend and Recent Performance

The financial grade for National Peroxide Ltd is very positive, supported by recent quarterly results. The company reported a remarkable 333.33% growth in net profit in the March 2026 quarter, marking two consecutive quarters of positive earnings momentum. Net sales reached a quarterly high of ₹85.68 crores, while PBDIT (Profit Before Depreciation, Interest and Taxes) hit ₹14.88 crores, with an operating profit margin of 17.37%. These figures demonstrate an improving operational efficiency and profitability trend, which could underpin future growth if sustained.

Technical Outlook

From a technical standpoint, the stock exhibits a bullish trend. Over the past three months, National Peroxide Ltd’s share price has surged by 47.32%, and it has gained 33.42% over six months. The one-month return of 8.87% further confirms recent positive price momentum. Despite a slight dip of -0.09% on the day of analysis, the technical indicators suggest that investor sentiment remains optimistic in the near term.

Market Position and Shareholding

National Peroxide Ltd is primarily promoter-owned, which often implies a stable shareholding structure and potential alignment of interests between management and shareholders. However, the stock’s microcap status means it may be subject to higher volatility and liquidity constraints compared to larger peers.

Investor Takeaway

For investors, the 'Hold' rating on National Peroxide Ltd reflects a balanced view of the company’s current prospects. While the stock’s valuation and recent financial trends are encouraging, the underlying quality concerns and historical operating profit decline warrant caution. The attractive valuation metrics may appeal to value-oriented investors seeking exposure to the commodity chemicals sector at a discount, but the below-average quality and past underperformance suggest that gains may be tempered by ongoing risks.

Investors should monitor upcoming quarterly results and market developments closely to assess whether the positive financial momentum can be sustained and translated into improved long-term fundamentals. The bullish technical trend offers some near-term optimism, but a prudent approach is advisable given the stock’s microcap nature and sector volatility.

Summary of Key Metrics as of 10 July 2026

- Mojo Score: 63.0 (Hold grade)
- Market Cap: Microcap
- 1 Year Return: -17.93%
- 6 Month Return: +33.42%
- Operating Profit CAGR (5 years): -24.68%
- Average ROE: 2.63%
- Price to Book Value: 0.9
- PEG Ratio: 0.1
- Recent Quarterly Net Sales: ₹85.68 crores
- Recent Quarterly PBDIT: ₹14.88 crores
- Operating Profit Margin (Quarterly): 17.37%

Overall, National Peroxide Ltd’s current 'Hold' rating by MarketsMOJO advises investors to maintain a watchful stance, recognising both the opportunities presented by its attractive valuation and improving financials, as well as the risks stemming from its quality challenges and past performance.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →